Advocates of lowering prescription drug prices are beginning to use an expensive new Alzheimer's drug to make the case for reform, but actually addressing the therapy's price raises complicated policy challenges.

Many Americans who thought their retirement planning was on track before the pandemic now find their plans detoured or even derailed. Fidelity’s State of Retirement Planning study examined the extent of planning Americans have undertaken to meet their retirement goals, how they feel about those efforts and the impact the COVID-19 pandemic has had on their preparation. The study also looks at ...

As companies design plans to bring workers back into the office, chief human resources officers are contending with a plethora of issues. Do they mandate vaccines or simply urge employees to get them? How should hybrid schedules be decided and does innovation suffer when people continue to work from home? These questions and more were ...

The Delta coronavirus variant is now the third-most common in California, new data show, underscoring the danger of the highly contagious strain to people who have not been vaccinated against COVID-19. The variant makes up 14.5% of California coronavirus cases analyzed so far in June, up from 4.7% in May, when it was the fourth-most ...

The California Chamber of Commerce and a coalition of business groups are urging state legislators to restore the net operating loss deduction and business incentive tax credits that were suspended and capped by AB 85 last year. The action was taken as part of last year’s strategy to close an estimated $54.3 billion budget deficit ...

A California jury has cleared CVS in a years-long lawsuit alleging the pharmacy giant overcharged them by more than $121 million for generic drugs. A group of insured pharmacy customers in six states filed suit against CVS Pharmacy in 2015, claiming that the company overcharged them and their insurers for generic drugs while charging low, ...